CN Patent

CN104856970B — 一种治疗ⅱ型糖尿病的维格列汀片剂

Assigned to Zhang Lei · Expires 2017-08-25 · 9y expired

What this patent protects

本发明属于医药制剂技术领域，公开了一种治疗Ⅱ型糖尿病的维格列汀片剂，该片剂是将原辅料混匀后直接压片而得，所述的原辅料包括维格列汀、葡萄糖酸、崩解剂和润滑剂。本发明在制备和储存过程中所含维格列汀基本无降解，质量稳定；制备方法采用直接压片法，工艺简单易控，易于工业化大生产。

USPTO Abstract

本发明属于医药制剂技术领域，公开了一种治疗Ⅱ型糖尿病的维格列汀片剂，该片剂是将原辅料混匀后直接压片而得，所述的原辅料包括维格列汀、葡萄糖酸、崩解剂和润滑剂。本发明在制备和储存过程中所含维格列汀基本无降解，质量稳定；制备方法采用直接压片法，工艺简单易控，易于工业化大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN104856970B
Jurisdiction
CN
Classification
—
Expires
2017-08-25
Drug substance claim
No
Drug product claim
No
Assignee
Zhang Lei
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.